Author:
van den Bos W.,de Bruin D. M.,Jurhill R. R.,Savci-Heijink C. D.,Muller B. G.,Varkarakis I. M.,Skolarikos A.,Zondervan P. J.,Laguna-Pes M. P.,Wijkstra H.,de Reijke T. M.,de la Rosette J. J. M. C. H.
Funder
Cure for cancer foundation
Endourological society
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29. doi: 10.3322/caac.21208
2. Valerio M, Ahmed HU, Emberton M et al (2013) The role of focal therapy in the management of localised prostate cancer: a systematic review. Eur Urol 44:1–20. doi: 10.1016/j.eururo.2013.05.048
3. Lee EW, Thai S, Kee ST (2010) Irreversible Electroporation : a novel image-guided cancer therapy. Gut Liver 4:99–104. doi: 10.5009/gnl.2010.4.S1.S99
4. Onik G, Rubinsky B (2010) First patient experience focal therapy of prostate cancer irreversible electroporation. Springer, Berlin, pp 235–247
5. Edd JF, Davalos RV (2007) Mathematical modeling of irreversible electroporation for treatment planning. Technol Cancer Res Treat 6:275–286